Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
SACUBITRIL/VALSARTAN IN HEART FAILURE WITH REDUCED EJECTION FRACTION: REAL-WORLD EXPERIENCE FROM ITALY (THE REAL.IT STUDY)
Anno:
2023
Background: Sacubitril/valsartan reduced heart failure (HF)-related hospitalizations and cardiovascular mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced ejection fraction (HFrEF). However, data of its routine real-world use is limited, and evidence from Italian settings is lacking. Aim of the study. The REAL.IT study aimed…